Author: Mitchell, Megan I.; Benâ€Dov, Iddo Z.; Liu, Christina; Ye, Kenny; Chow, Kar; Kramer, Yael; Gangadharan, Anju; Park, Steven; Fitzgerald, Sean; Ramnauth, Andrew; Perlin, David S.; Donato, Michele; Bhoy, Emily; Manouchehri Doulabi, Ehsan; Poulos, Michael; Kamaliâ€Moghaddam, Masood; Loudig, Olivier
Title: Extracellular Vesicle Capture by AnTibody of CHoice and Enzymatic Release (EVâ€CATCHER): A customizable purification assay designed for smallâ€RNA biomarker identification and evaluation of circulating smallâ€EVs Cord-id: yaqy5gyi Document date: 2021_6_3
ID: yaqy5gyi
Snippet: Circulating nucleic acids, encapsulated within small extracellular vesicles (EVs), provide a remote cellular snapshot of biomarkers derived from diseased tissues, however selective isolation is critical. Current laboratoryâ€based purification techniques rely on the physical properties of smallâ€EVs rather than their inherited cellular fingerprints. We established a highlyâ€selective purification assay, termed EVâ€CATCHER, initially designed for highâ€throughput analysis of lowâ€abundance s
Document: Circulating nucleic acids, encapsulated within small extracellular vesicles (EVs), provide a remote cellular snapshot of biomarkers derived from diseased tissues, however selective isolation is critical. Current laboratoryâ€based purification techniques rely on the physical properties of smallâ€EVs rather than their inherited cellular fingerprints. We established a highlyâ€selective purification assay, termed EVâ€CATCHER, initially designed for highâ€throughput analysis of lowâ€abundance smallâ€RNA cargos by nextâ€generation sequencing. We demonstrated its selectivity by specifically isolating and sequencing smallâ€RNAs from mouse smallâ€EVs spiked into human plasma. Western blotting, nanoparticle tracking, and transmission electron microscopy were used to validate and quantify the capture and release of intact smallâ€EVs. As proofâ€ofâ€principle for sensitive detection of circulating miRNAs, we compared smallâ€RNA sequencing data from a subset of smallâ€EVs serumâ€purified with EVâ€CATCHER to data from whole serum, using samples from a small cohort of recently hospitalized Covidâ€19 patients. We identified and validated, only in smallâ€EVs, hsaâ€miRâ€146a and hsaâ€miRâ€126â€3p to be significantly downregulated with disease severity. Separately, using convalescent sera from recovered Covidâ€19 patients with high antiâ€spike IgG titers, we confirmed the neutralizing properties, against SARSâ€CoVâ€2 in vitro, of a subset of smallâ€EVs serumâ€purified by EVâ€CATCHER, as initially observed with ultracentrifuged smallâ€EVs. Altogether our data highlight the sensitivity and versatility of EVâ€CATCHER.
Search related documents:
Co phrase search for related documents, hyperlinks ordered by date